These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17536073)

  • 21. Neurodevelopmental outcome of appropriate and small for gestational age very low birth weight infants.
    Procianoy RS; Koch MS; Silveira RC
    J Child Neurol; 2009 Jul; 24(7):788-94. PubMed ID: 19289693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study.
    Reinehr T; Toschke AM
    Arch Pediatr Adolesc Med; 2009 Aug; 163(8):709-15. PubMed ID: 19652102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF; Diehl AM
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and body composition in preterm born children during prepubertal ages.
    Darendeliler F; Bas F; Bundak R; Coban A; Sancakli O; Eryilmaz SK; Kucukemre B; Disci R; Gokcay G; Aki S; Ince Z; Eskiyurt N
    Clin Endocrinol (Oxf); 2008 May; 68(5):773-9. PubMed ID: 17980003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of methionine in vivo: impact of pregnancy, protein restriction, and fatty liver disease.
    Kalhan SC
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():121-31; discussion 131-3, 259-68. PubMed ID: 19346772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
    Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic complications of childhood obesity: identifying and mitigating the risk.
    Weiss R; Kaufman FR
    Diabetes Care; 2008 Feb; 31 Suppl 2():S310-6. PubMed ID: 18227502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
    Schwimmer JB
    Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are intrauterine growth restriction and preterm birth associated with dental caries?
    Saraiva MC; Bettiol H; Barbieri MA; Silva AA
    Community Dent Oral Epidemiol; 2007 Oct; 35(5):364-76. PubMed ID: 17822485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intelligence of very preterm or very low birthweight infants in young adulthood.
    Weisglas-Kuperus N; Hille ET; Duivenvoorden HJ; Finken MJ; Wit JM; van Buuren S; van Goudoever JB; Verloove-Vanhorick SP;
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F196-200. PubMed ID: 18805824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth patterns in children with intrauterine growth retardation and their correlation to neurocognitive development.
    Fattal-Valevski A; Toledano-Alhadef H; Leitner Y; Geva R; Eshel R; Harel S
    J Child Neurol; 2009 Jul; 24(7):846-51. PubMed ID: 19617460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.
    Koebnick C; Getahun D; Reynolds K; Coleman KJ; Porter AH; Lawrence JM; Punyanitya M; Quinn VP; Jacobsen SJ
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):597-603. PubMed ID: 19412009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric nonalcoholic fatty liver disease in 2009.
    Alisi A; Manco M; Vania A; Nobili V
    J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
    [No Abstract]   [Full Text] [Related]  

  • 38. Relation between intrauterine growth and subsequent intellectual disability in a ten-year population cohort of children in Western Australia.
    Leonard H; Nassar N; Bourke J; Blair E; Mulroy S; de Klerk N; Bower C
    Am J Epidemiol; 2008 Jan; 167(1):103-11. PubMed ID: 17898000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal sleep deprivation is a risk factor for small for gestational age: a cohort study.
    Abeysena C; Jayawardana P; DE A Seneviratne R
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):382-7. PubMed ID: 19694692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.